Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
240 participants
INTERVENTIONAL
2025-10-01
2042-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Slow Age: Interventions to Slow Aging in Humans
NCT05593939
The Impact of a Fast Diet and Calorie Mimetic Supplements on Epigenetic Aging
NCT04962464
Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress
NCT02132091
Fisetin Supplementation for Healthy Aging
NCT07195318
Mechanisms to Reduce Mental and Physical Fatigue Following Exercise Training in Older Adults
NCT05484661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRF
Time-restricted feeding
Time-restricted feeding in a 16/8 regimen - 16 hours of fast and 8 hours of eating per day.
EXE
Exercise - Strength + Cardio
Supervised strength training 2x/week + self-administered cardio training 2x/week.
FAX
Time-restricted feeding + Exercise
Strength and cardio exercise 2x/week each combined with time-restricted feeding in a 16/8 regimen.
CON
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise - Strength + Cardio
Supervised strength training 2x/week + self-administered cardio training 2x/week.
Time-restricted feeding
Time-restricted feeding in a 16/8 regimen - 16 hours of fast and 8 hours of eating per day.
Time-restricted feeding + Exercise
Strength and cardio exercise 2x/week each combined with time-restricted feeding in a 16/8 regimen.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Aged \>20 years
* In good general health meaning maximally 1 well-managed chronic disease
* Non-smoker.
Exclusion Criteria
* Inability or unwillingness to perform the prescribed physical exercise
* Treatment with other investigational drug or intervention within 1 year
* \>1 hour of systematic strenuous exercise or strength training a week
* Current time-restricted eating habits
* Severe or dysregulated medical disease (i.e. active cancer, uncontrolled diabetes, severe pulmonary or heart disease)
* \>1 well-managed chronic disease
* Smoker
* Use of systemic glucocorticoids, androgens or antiandrogens.
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen
Copenhagen, Copenhagen N, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-25020642
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.